- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/40 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
Patent holdings for IPC class C07C 235/40
Total number of patents in this class: 106
10-year publication summary
|
10
|
8
|
8
|
8
|
7
|
9
|
8
|
6
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Research Foundation for The State University of New York | 1768 |
5 |
| Dongjin Semichem Co., Ltd. | 515 |
4 |
| Allergan, Inc. | 2148 |
3 |
| Eli Lilly and Company | 4118 |
3 |
| Pierre Fabre Medicament | 514 |
3 |
| Sanofi | 4326 |
3 |
| Novartis AG | 10169 |
2 |
| The Regents of the University of California | 20902 |
2 |
| Centre National de La Recherche Scientifique | 11111 |
2 |
| Ajinomoto Co., Inc. | 2284 |
2 |
| Northwestern University | 3570 |
2 |
| Daicel Corporation | 2562 |
2 |
| Ideaya Biosciences, Inc. | 163 |
2 |
| Kyushu University, National University Corporation | 1732 |
2 |
| Mcmaster University | 834 |
2 |
| Mitsubishi Gas Chemical Company, Inc. | 3643 |
2 |
| Musc Foundation for Research Development | 371 |
2 |
| Research Triangle Institute | 419 |
2 |
| Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory | 101 |
2 |
| Temisis | 2 |
2 |
| Other owners | 57 |